These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33172499)

  • 1. Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer's disease patients.
    Lemmens S; Van Craenendonck T; Van Eijgen J; De Groef L; Bruffaerts R; de Jesus DA; Charle W; Jayapala M; Sunaric-Mégevand G; Standaert A; Theunis J; Van Keer K; Vandenbulcke M; Moons L; Vandenberghe R; De Boever P; Stalmans I
    Alzheimers Res Ther; 2020 Nov; 12(1):144. PubMed ID: 33172499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease.
    Hadoux X; Hui F; Lim JKH; Masters CL; Pébay A; Chevalier S; Ha J; Loi S; Fowler CJ; Rowe C; Villemagne VL; Taylor EN; Fluke C; Soucy JP; Lesage F; Sylvestre JP; Rosa-Neto P; Mathotaarachchi S; Gauthier S; Nasreddine ZS; Arbour JD; Rhéaume MA; Beaulieu S; Dirani M; Nguyen CTO; Bui BV; Williamson R; Crowston JG; van Wijngaarden P
    Nat Commun; 2019 Sep; 10(1):4227. PubMed ID: 31530809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.
    den Haan J; Csinscik L; Parker T; Paterson RW; Slattery CF; Foulkes A; Bouwman FH; Verbraak FD; Scheltens P; Peto T; Lengyel I; Schott JM; Crutch SJ; Shakespeare TJ; Yong KXX
    Alzheimers Res Ther; 2019 Jul; 11(1):62. PubMed ID: 31319885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease.
    Ferrari L; Huang SC; Magnani G; Ambrosi A; Comi G; Leocani L
    J Alzheimers Dis; 2017; 56(3):1101-1107. PubMed ID: 28106555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuro-Retina Might Reflect Alzheimer's Disease Stage.
    Santangelo R; Huang SC; Bernasconi MP; Falautano M; Comi G; Magnani G; Leocani L
    J Alzheimers Dis; 2020; 77(4):1455-1468. PubMed ID: 32925026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal retinal layer changes in preclinical Alzheimer's disease.
    van de Kreeke JA; Nguyen HT; Konijnenberg E; Tomassen J; den Braber A; Ten Kate M; Yaqub M; van Berckel B; Lammertsma AA; Boomsma DI; Tan HS; Visser PJ; Verbraak FD
    Acta Ophthalmol; 2021 Aug; 99(5):538-544. PubMed ID: 33073531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential new diagnostic tool for Alzheimer's disease using a linear discriminant function for Fourier domain optical coherence tomography.
    Larrosa JM; Garcia-Martin E; Bambo MP; Pinilla J; Polo V; Otin S; Satue M; Herrero R; Pablo LE
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):3043-51. PubMed ID: 24736054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease.
    Cheung CY; Ong YT; Hilal S; Ikram MK; Low S; Ong YL; Venketasubramanian N; Yap P; Seow D; Chen CL; Wong TY
    J Alzheimers Dis; 2015; 45(1):45-56. PubMed ID: 25428254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-regression framework to improve diagnostic ability of optical coherence tomography retinal biomarkers to discriminate mild cognitive impairment and Alzheimer's disease.
    Chua J; Li C; Ho LKH; Wong D; Tan B; Yao X; Gan A; Schwarzhans F; Garhöfer G; Sng CCA; Hilal S; Venketasubramanian N; Cheung CY; Fischer G; Vass C; Wong TY; Chen CL; Schmetterer L
    Alzheimers Res Ther; 2022 Mar; 14(1):41. PubMed ID: 35272711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning based on Optical Coherence Tomography images as a diagnostic tool for Alzheimer's disease.
    Wang X; Jiao B; Liu H; Wang Y; Hao X; Zhu Y; Xu B; Xu H; Zhang S; Jia X; Xu Q; Liao X; Zhou Y; Jiang H; Wang J; Guo J; Yan X; Tang B; Zhao R; Shen L
    CNS Neurosci Ther; 2022 Dec; 28(12):2206-2217. PubMed ID: 36089740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease.
    More SS; Beach JM; McClelland C; Mokhtarzadeh A; Vince R
    ACS Chem Neurosci; 2019 Nov; 10(11):4492-4501. PubMed ID: 31603648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased retinal thickness in patients with Alzheimer's disease is correlated with disease severity.
    Kim JI; Kang BH
    PLoS One; 2019; 14(11):e0224180. PubMed ID: 31689310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of Focal Thinning of the Ganglion Cell-Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Shao Y; Jiang H; Wei Y; Shi Y; Shi C; Wright CB; Sun X; Vanner EA; Rodriguez AD; Lam BL; Rundek T; Baumel BS; Gameiro GR; Dong C; Wang J
    J Alzheimers Dis; 2018; 64(4):1261-1273. PubMed ID: 30040712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer's disease.
    Lim JKH; Li QX; Ryan T; Bedggood P; Metha A; Vingrys AJ; Bui BV; Nguyen CTO
    Sci Rep; 2021 Mar; 11(1):6387. PubMed ID: 33737550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between retinal structure and brain multimodal magnetic resonance imaging in patients with Alzheimer's disease.
    Hao X; Zhang W; Jiao B; Yang Q; Zhang X; Chen R; Wang X; Xiao X; Zhu Y; Liao W; Wang D; Shen L
    Front Aging Neurosci; 2023; 15():1088829. PubMed ID: 36909943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals.
    López-de-Eguileta A; López-García S; Lage C; Pozueta A; García-Martínez M; Kazimierczak M; Bravo M; Irure J; López-Hoyos M; Muñoz-Cacho P; Rodríguez-Perez N; Tordesillas-Gutiérrez D; Goikoetxea A; Nebot C; Rodríguez-Rodríguez E; Casado A; Sánchez-Juan P
    Alzheimers Res Ther; 2022 Apr; 14(1):57. PubMed ID: 35449033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinal Imaging as Potential Biomarkers for Dementia].
    Sasaki M
    Brain Nerve; 2021 Nov; 73(11):1209-1216. PubMed ID: 34759057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease.
    Sánchez D; Castilla-Marti M; Rodríguez-Gómez O; Valero S; Piferrer A; Martínez G; Martínez J; Serra J; Moreno-Grau S; Hernández-Olasagarre B; De Rojas I; Hernández I; Abdelnour C; Rosende-Roca M; Vargas L; Mauleón A; Santos-Santos MA; Alegret M; Ortega G; Espinosa A; Pérez-Cordón A; Sanabria Á; Ciudin A; Simó R; Hernández C; Villoslada P; Ruiz A; Tàrraga L; Boada M
    Sci Rep; 2018 Nov; 8(1):16345. PubMed ID: 30397251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal imaging in Alzheimer's disease.
    Cheung CY; Mok V; Foster PJ; Trucco E; Chen C; Wong TY
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):983-994. PubMed ID: 34108266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    Ge YJ; Xu W; Ou YN; Qu Y; Ma YH; Huang YY; Shen XN; Chen SD; Tan L; Zhao QH; Yu JT
    Ageing Res Rev; 2021 Aug; 69():101361. PubMed ID: 34000463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.